Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Sanders

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ovarian function following marrow transplantation for aplastic anemia or leukemiaJ E Sanders, C D Buckner, D Amos, et al.
Blood|August 1, 1988
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationK M Sullivan, R P Witherspoon, R Storb, et al.
Bone Marrow Transplantation|August 22, 2002
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantationJ S McCune, T Gooley, J P Gibbs, et al.
Journal of Clinical Apheresis|January 1, 1984
Granulocyte collection by continuous-flow centrifugation using arteriovenous shuntsB M Williams, R A Clift, C D Buckner, et al.
American Journal of Hematology|October 1, 1984
Marrow transplantation in hepatitis-associated aplastic anemiaR P Witherspoon, R Storb, H Shulman, et al.
Bone Marrow Transplantation|June 1, 1990
Gynecological abnormalities following allogeneic bone marrow transplantationM A Schubert, K M Sullivan, M M Schubert, et al.
Bone Marrow Transplantation|January 1, 1995
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignanciesM H Lynch, F B Petersen, F R Appelbaum, et al.
Haematology and Blood Transfusion|January 1, 1990
Marrow grafting for acute leukemia: results and future treatment strategiesR Storb, C D Buckner, R A Clift, et al.
Blood|April 1, 1996
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantationJ E Sanders, J Hawley, W Levy, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Blood|August 1, 1988
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseK M Sullivan, R P Witherspoon, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ovarian function following marrow transplantation for aplastic anemia or leukemiaJ E Sanders, C D Buckner, D Amos, et al.
Blood|August 1, 1988
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantationK M Sullivan, R P Witherspoon, R Storb, et al.
Bone Marrow Transplantation|August 22, 2002
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantationJ S McCune, T Gooley, J P Gibbs, et al.
Journal of Clinical Apheresis|January 1, 1984
Granulocyte collection by continuous-flow centrifugation using arteriovenous shuntsB M Williams, R A Clift, C D Buckner, et al.
American Journal of Hematology|October 1, 1984
Marrow transplantation in hepatitis-associated aplastic anemiaR P Witherspoon, R Storb, H Shulman, et al.
Bone Marrow Transplantation|June 1, 1990
Gynecological abnormalities following allogeneic bone marrow transplantationM A Schubert, K M Sullivan, M M Schubert, et al.
Bone Marrow Transplantation|January 1, 1995
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignanciesM H Lynch, F B Petersen, F R Appelbaum, et al.
Haematology and Blood Transfusion|January 1, 1990
Marrow grafting for acute leukemia: results and future treatment strategiesR Storb, C D Buckner, R A Clift, et al.
Blood|April 1, 1996
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantationJ E Sanders, J Hawley, W Levy, et al.
Pageof 25